Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO29865 | FSTL4 Knockout cell line (HeLa) | Human | FSTL4 | 1:3~1:6 | Negative | Online Inquiry |
KO29866 | FSTL4 Knockout cell line (HEK293) | Human | FSTL4 | 1:3~1:6 | Negative | Online Inquiry |
FSTL4 Gene Knockout Cell Lines are genetically engineered cell lines that have undergone targeted gene disruption of the FSTL4 gene, which encodes for the protein Follistatin-like 4. This product serves as a powerful tool for researchers investigating the role of FSTL4 in various biological processes, including inflammation, immune response, and cellular signaling pathways. By providing a system to study the functional consequences of ablating FSTL4 expression, these knockout cell lines enable a deeper understanding of disease mechanisms and potential therapeutic targets.
The principal mechanism through which FSTL4 influences biological outcomes involves its modulation of cytokine activity, particularly in the context of inflammation and cellular growth. By knocking out the FSTL4 gene, researchers can elucidate its role in mediating responses to inflammatory stimuli and other cellular signals. This functionality is crucial for investigating the gene's involvement in autoimmune diseases, cancer, and metabolic disorders.
The scientific importance of FSTL4 Gene Knockout Cell Lines in research and clinical settings is underscored by their applications in drug development and biomarker discovery. Their ability to provide insights into FSTL4's involvement in pathophysiology can guide the development of targeted therapies and enhance our understanding of disease biology.
What sets these knockout cell lines apart from conventional models is their specificity and precision in gene targeting, allowing for more reliable and reproducible experimental results. Unlike existing systems, such as those utilizing transient transfection or non-specific knockdown methods, FSTL4 knockout cells offer permanent gene ablation, ensuring that researchers can confidently assess the physiological and pathological roles of FSTL4 over time.
For researchers and clinicians alike, FSTL4 Gene Knockout Cell Lines are invaluable resources that aid in unraveling complex biological questions and advancing translational research. They present an essential platform for innovation in therapeutic strategies and hold promise for contributions to significant advancements in health care.
As a leader in biotechnological solutions, our company specializes in providing high-quality, customizable biological products designed to meet the evolving needs of the scientific community. We are committed to supporting your research with superior products, technical expertise, and comprehensive customer support.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.